O

OrbiMed Portfolio holdings

AUM $4.17B
1-Year Est. Return 30.9%
This Quarter Est. Return
1 Year Est. Return
+30.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.98B
AUM Growth
-$187M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
122
New
Increased
Reduced
Closed

Top Buys

1
+$81.1M
2
+$42.1M
3
+$31.3M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$22.4M
5
CTMX icon
CytomX Therapeutics
CTMX
+$19.2M

Top Sells

1
+$97.6M
2
+$76.6M
3
+$62.4M
4
SWTX
SpringWorks Therapeutics
SWTX
+$41.9M
5
XTNT icon
Xtant Medical Holdings
XTNT
+$34.4M

Sector Composition

1 Healthcare 99.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
101
Gilead Sciences
GILD
$155B
– –
-197,500
INMB icon
102
INmune Bio
INMB
$38M
– –
0
IONS icon
103
Ionis Pharmaceuticals
IONS
$11.3B
– –
-2,540,136
IVVD icon
104
Invivyd
IVVD
$548M
– –
-933,500
NKTX icon
105
Nkarta
NKTX
$134M
– –
-821,400
NXTC icon
106
NextCure
NXTC
$26.5M
– –
-95,100
PFE icon
107
Pfizer
PFE
$142B
– –
-3,850,200
PHGE icon
108
BiomX
PHGE
$9.29M
– –
-1,787,767
SLRN
109
DELISTED
ACELYRIN
SLRN
– –
-4,001,711
SRRK icon
110
Scholar Rock
SRRK
$3.6B
– –
-151,800
SWTX
111
DELISTED
SpringWorks Therapeutics
SWTX
– –
-950,200
TIL icon
112
Instil Bio
TIL
$97.3M
– –
-116,785
TNGX icon
113
Tango Therapeutics
TNGX
$1.1B
– –
-550,000
VERA icon
114
Vera Therapeutics
VERA
$1.81B
– –
-481,065
VSTM icon
115
Verastem
VSTM
$504M
– –
-2,862,448
XBI icon
116
State Street SPDR S&P Biotech ETF
XBI
$6.6B
– –
0
XFOR icon
117
X4 Pharmaceuticals
XFOR
$320M
– –
-225,884
XTNT icon
118
Xtant Medical Holdings
XTNT
$92.4M
– –
-73,114,592
BCAX
119
Bicara Therapeutics
BCAX
$781M
– –
-298,301
CBLL
120
CeriBell Inc
CBLL
$463M
– –
-112,500
KMTS
121
Kestra Medical Technologies
KMTS
$1.29B
– –
-250,000
1 2 3 4
5